Inactive Instrument
Acusphere, Inc. Share Price Other OTC
Stocks
US00511R8705
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 06/11/13 | Acusphere Appoints William Ramage as Chief Development Officer | CI |
| 21/10/13 | Acusphere, Inc. has Changed its Ticker to ACUS from ACUSD | CI |
| Market Cap | 3.46M 3M 2.81M 2.57M 4.83M 330M 4.91M 32.86M 12.9M 165M 13.01M 12.73M 552M | P/E 2006 |
-1.06x | P/E 2007 | -0.49x |
|---|---|---|---|---|---|
| Enterprise Value | -11.29M -9.79M -9.15M -8.36M -15.74M -1.08B -16.01M -107M -42.05M -539M -42.39M -41.48M -1.8B | EV / Sales 2006 |
9,811,030x | EV / Sales 2007 | 5,744,305x |
| Free-Float |
100% | Yield 2006 * |
-
| Yield 2007 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.03% | -2.32% | +22.53% | +68.67% | 49.03B | ||
| -1.14% | +13.15% | +60.80% | +127.29% | 42.33B | ||
| +0.27% | -0.37% | -1.22% | +15.93% | 12.43B | ||
| +0.43% | -0.69% | +19.53% | +69.15% | 11.68B | ||
| -0.19% | +0.19% | +30.98% | +140.74% | 9.12B | ||
| +3.81% | +8.39% | +22.04% | +39.32% | 7.15B | ||
| +1.62% | +1.47% | +41.67% | -12.77% | 7.09B | ||
| -1.22% | +0.78% | +11.47% | +171.70% | 6.76B | ||
| +0.03% | +8.29% | -24.59% | +28.71% | 5.95B | ||
| Average | +0.40% | +2.39% | +20.36% | +72.08% | 16.84B | |
| Weighted average by Cap. | -0.08% | +1.73% | +30.08% | +82.92% |
| 2006 | 2007 | |
|---|---|---|
| Net sales | 1.78 1.54 1.44 1.32 2.48 169.71 2.52 16.89 6.63 84.96 6.69 6.54 283.6 | 2.67 2.31 2.16 1.97 3.72 254.14 3.78 25.29 9.93 127.23 10.01 9.8 424.69 |
| Net income | -61.09M -52.93M -49.48M -45.23M -85.13M -5.82B -86.6M -579M -227M -2.91B -229M -224M -9.73B | -53.73M -46.56M -43.52M -39.78M -74.87M -5.12B -76.17M -509M -200M -2.56B -202M -197M -8.56B |
| Net Debt | -52.87M -45.81M -42.83M -39.15M -73.68M -5.04B -74.95M -501M -197M -2.52B -198M -194M -8.42B | -14.76M -12.79M -11.95M -10.93M -20.57M -1.41B -20.92M -140M -54.95M -704M -55.4M -54.2M -2.35B |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
















